Skip to main content
. 2019 May 10;8(8):1608132. doi: 10.1080/2162402X.2019.1608132

Figure 4.

Figure 4.

Neoantigen quality is associated with overall survival of melanoma patients treated with ICB. (a) Kaplan–Meier survival analysis of neoantigen quality. (b) Multivariate Cox regression analysis of neoantigen quality model by taking into account confounding factors such as age, gender, tumor stage and hypermutation status.